BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Manso Y, Comes G, López-Ramos JC, Belfiore M, Molinero A, Giralt M, Carrasco J, Adlard PA, Bush AI, Delgado-García JM, Hidalgo J. Overexpression of Metallothionein-1 Modulates the Phenotype of the Tg2576 Mouse Model of Alzheimer's Disease. J Alzheimers Dis 2016;51:81-95. [PMID: 26836194 DOI: 10.3233/JAD-151025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Choo XY, Mcinnes LE, Grubman A, Wasielewska JM, Belaya I, Burrows E, Quek H, Martín JC, Loppi S, Sorvari A, Rait D, Powell A, Duncan C, Liddell JR, Tanila H, Polo JM, Malm T, Kanninen KM, Donnelly PS, White AR. Novel Anti-Neuroinflammatory Properties of a Thiosemicarbazone–Pyridylhydrazone Copper(II) Complex. IJMS 2022;23:10722. [DOI: 10.3390/ijms231810722] [Reference Citation Analysis]
2 Miller HC, Louw R, Mereis M, Venter G, Boshoff JD, Mienie L, van Reenen M, Venter M, Lindeque JZ, Domínguez-Martínez A, Quintana A, van der Westhuizen FH. Metallothionein 1 Overexpression Does Not Protect Against Mitochondrial Disease Pathology in Ndufs4 Knockout Mice. Mol Neurobiol 2021;58:243-62. [PMID: 32918239 DOI: 10.1007/s12035-020-02121-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
3 Nyúl-Tóth Á, Tarantini S, Kiss T, Toth P, Galvan V, Tarantini A, Yabluchanskiy A, Csiszar A, Ungvari Z. Increases in hypertension-induced cerebral microhemorrhages exacerbate gait dysfunction in a mouse model of Alzheimer's disease. Geroscience 2020;42:1685-98. [PMID: 32844283 DOI: 10.1007/s11357-020-00256-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
4 Escrig A, Molinero A, Méndez B, Giralt M, Comes G, Sanchis P, Fernández-Gayol O, Giménez-Llort L, Becker-Pauly C, Rose-John S, Hidalgo J. IL-6 Trans-Signaling in the Brain Influences the Metabolic Phenotype of the 3xTg-AD Mouse Model of Alzheimer's Disease. Cells 2020;9:E1605. [PMID: 32630818 DOI: 10.3390/cells9071605] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chen NC, Chen HL, Li SH, Chang YH, Chen MH, Tsai NW, Yu CC, Yang SY, Lu CH, Lin WC. Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson's Disease. Front Aging Neurosci 2020;12:112. [PMID: 32410983 DOI: 10.3389/fnagi.2020.00112] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
6 Wong DL, Stillman MJ. Metallothionein: An Aggressive Scavenger-The Metabolism of Rhodium(II) Tetraacetate (Rh2(CH3CO2)4). ACS Omega 2018;3:16314-27. [PMID: 31458267 DOI: 10.1021/acsomega.8b02161] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
7 Atrián-Blasco E, Santoro A, Pountney DL, Meloni G, Hureau C, Faller P. Chemistry of mammalian metallothioneins and their interaction with amyloidogenic peptides and proteins. Chem Soc Rev 2017;46:7683-93. [PMID: 29114657 DOI: 10.1039/c7cs00448f] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 8.3] [Reference Citation Analysis]
8 Okita Y, Rcom-H'cheo-Gauthier AN, Goulding M, Chung RS, Faller P, Pountney DL. Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies. Front Neurosci 2017;11:114. [PMID: 28420950 DOI: 10.3389/fnins.2017.00114] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
9 Comes G, Manso Y, Escrig A, Fernandez-Gayol O, Sanchis P, Molinero A, Giralt M, Carrasco J, Hidalgo J. Influence of Transgenic Metallothionein-1 on Gliosis, CA1 Neuronal Loss, and Brain Metal Levels of the Tg2576 Mouse Model of Alzheimer's Disease. Int J Mol Sci 2017;18:E251. [PMID: 28134760 DOI: 10.3390/ijms18020251] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]